1. DOP08 Serum proteomics predict endoscopic remission in patients with Crohn's Disease. (27th May 2021) Authors: Alsoud, D; Sudhakar, P; Sabino, J; Ferrante, M; Verstockt, B; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P062 Effects of exposure to steroids on the PredictSURE whole blood prognostic assay in Inflammatory Bowel Disease. (27th May 2021) Authors: Alsoud, D; Verstockt, S; Sabino, J; Ferrante, M; Noor, N; Verstockt, B; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P257 The clinical decision support tool has low performance in predicting outcome to ustekinumab in Crohn's disease. (21st January 2022) Authors: Alsoud, D; Sabino, J; Ferrante, M; Verstockt, B; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P309 Are results from VARSITY applicable to real world? Adalimumab versus vedolizumab as first line biological in moderate-to-severe IBD. (27th May 2021) Authors: Moens, A; Verstockt, B; Alsoud, D; Sabino, J; Ferrante, M; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P401 Tofacitinib tissue exposure correlates with endoscopic outcome. (21st January 2022) Authors: Verstockt, B; Alsoud, D; van Oostrom, J; Smith, J; Stylli, J; Singh, S; van Gennep, S; Rahimian, P; Sabino, J; Ferrante, M; Singh, S; D'Haens, G; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P441 Adalimumab versus ustekinumab as first-line biological in a real-life cohort of moderate-to-severe Crohn's disease. (21st January 2022) Authors: Moens, A; Verstockt, B; Alsoud, D; Sabino, J; Ferrante, M; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P442 Real-world endoscopic and histologic outcomes are linked to ustekinumab exposure in Ulcerative Colitis. (21st January 2022) Authors: Alsoud, D; Compernolle, G; Tops, S; Sabino, J; Ferrante, M; Thomas, D; De Hertogh, G; Vermeire, S; Verstockt, B Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P447 Positioning of ustekinumab affects its effectiveness, drug persistence and serum exposure in Crohn's disease. (21st January 2022) Authors: Alsoud, D; Sabino, J; Ferrante, M; Vermeire, S; Verstockt, B Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P465 One year endoscopic and histologic outcomes to tofacitinib therapy in refractory ulcerative colitis. (27th May 2021) Authors: Verstockt, B; Aden, K; Alsoud, D; Outtier, A; Sabino, J; Rosenstiel, P; Vermeire, S; De Hertogh, G; Schreiber, S; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P576 Real-world effectiveness and safety of risankizumab in patients with moderate-to-severe multi-refractory Crohn's disease: a Belgian multi-centric cohort study. (21st January 2022) Authors: Alsoud, D; Franchimont, D; D'Heygere, F; Bossuyt, P; Vijverman, A; Van Hootegem, P; Sabino, J; Cremer, A; Vermeire, S; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗